CTKB earnings: real EPS beat/miss history, analyst consensus Buy, P/E -7.87. Updated 2026-07-23.
Cytek Biosciences (CTKB) Research Hub
Cytek Biosciences (CTKB) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-09-11, shares last closed at 4.61 USD (-2.54%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -7.87, market cap 0.59B. This hub links to the full technical, earnings and options research available for CTKB.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 4.61 USD (-2.54%) |
| 52-week range | 3.77 USD – 4.93 USD |
| Trend regime | Range |
| 14-day RSI | 61.5 (Bullish) |
| Trailing P/E | -7.87 |
| Market cap | 0.59B |
| Dividend yield | 0.00% |
Available research for CTKB
Covered Call on CTKB: how it works, illustrative setup around the real 4.61 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CTKB: how it works, illustrative setup around the real 4.61 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CTKB: how it works, illustrative setup around the real 4.61 USD price, max profit/loss, breakeven and when to use it. Educational.
CTKB technical analysis: range, last 4.61 USD, RSI 61.5, 52w range 3.77 USD–4.93 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is CTKB in?
Cytek Biosciences (CTKB) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is CTKB in an uptrend or downtrend?
As of 2026-09-11, CTKB is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CTKB's trailing P/E ratio?
CTKB's trailing P/E is -7.87, with a market cap of 0.59B. See the earnings research page for full valuation detail.